Literature DB >> 19281264

Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.

Amit Mor1, Eugenia Segal, Brenda Mester, Boris Arshava, Osnat Rosen, Fa-Xiang Ding, Joseph Russo, Amnon Dafni, Fabian Schvartzman, Tali Scherf, Fred Naider, Jacob Anglister.   

Abstract

The third variable region (V3) of the HIV-1 envelope glycoprotein gp120 is a target for virus neutralizing antibodies. The V3 sequence determines whether the virus will manifest R5 or X4 phenotypes and use the CCR5 or CXCR4 chemokine coreceptor, respectively. Previous NMR studies revealed that both R5- and X4-V3 peptides bound to antibodies 0.5beta and 447-52D form beta-hairpin conformations with the GPGR segment at the turn. In contrast, in their free form, linear V3 peptides and a cyclic peptide consisting of the entire 35-residue V3 loop were highly unstructured in aqueous solution. Herein we evaluated a series of synthetic disulfide constrained V3-peptides in which the position of the disulfide bonds, and therefore the ring size, was systematically varied. NMR structures determined for singly and doubly disulfide constrained V3-peptides in aqueous solution were compared with those found for unconstrained V3(JRFL) and V3(IIIB) peptides bound to 447-52D and to 0.5beta, respectively. Our study indicated that cyclic V3 peptides manifested significantly reduced conformational space compared to their linear homologues and that in all cases cyclic peptides exhibited cross-strand interactions suggestive of beta-hairpin-like structures. Nevertheless, the singly constrained V3-peptides retained significant flexibility and did not form an idealized beta-hairpin. Incorporation of a second disulfide bond results in significant overall rigidity, and in one case, a structure close to that of V3(MN) peptide bound to 447-52D Fab was assumed and in another case a structure close to that formed by the linear V3(IIIB) peptide bound to antibody 0.5beta was assumed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19281264      PMCID: PMC2756766          DOI: 10.1021/bi802308n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  65 in total

1.  Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.

Authors:  R Stanfield; E Cabezas; A Satterthwait; E Stura; A Profy; I Wilson
Journal:  Structure       Date:  1999-02-15       Impact factor: 5.006

2.  Using NMRView to visualize and analyze the NMR spectra of macromolecules.

Authors:  Bruce A Johnson
Journal:  Methods Mol Biol       Date:  2004

Review 3.  NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity.

Authors:  Michal Sharon; Osnat Rosen; Jacob Anglister
Journal:  Curr Opin Drug Discov Devel       Date:  2005-09

4.  Solution conformation of a peptide corresponding to the principal neutralizing determinant of HIV-1IIIB: a two-dimensional NMR study.

Authors:  A Zvi; R Hiller; J Anglister
Journal:  Biochemistry       Date:  1992-08-04       Impact factor: 3.162

5.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

6.  The complete Consensus V3 loop peptide of the envelope protein gp120 of HIV-1 shows pronounced helical character in solution.

Authors:  W F Vranken; M Budesinsky; F Fant; K Boulez; F A Borremans
Journal:  FEBS Lett       Date:  1995-10-23       Impact factor: 4.124

7.  Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope.

Authors:  N L Letvin; S Robinson; D Rohne; M K Axthelm; J W Fanton; M Bilska; T J Palker; H X Liao; B F Haynes; D C Montefiori
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Secondary structural elements as a basis for antibody recognition in the immunodominant region of human immunodeficiency viruses 1 and 2.

Authors:  R L Markert; H Ruppach; S Gehring; U Dietrich; D F Mierke; M Köck; H Rübsamen-Waigmann; C Griesinger
Journal:  Eur J Biochem       Date:  1996-04-01

9.  Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1.

Authors:  D A Resnick; A D Smith; S C Gesiler; A Zhang; E Arnold; G F Arnold
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Characterization of V3 loop-Pseudomonas exotoxin chimeras. Candidate vaccines for human immunodeficiency virus-1.

Authors:  D J FitzGerald; C M Fryling; M L McKee; J C Vennari; T Wrin; M E Cromwell; A L Daugherty; R J Mrsny
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.486

View more
  6 in total

1.  Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.

Authors:  Andreja Majerle; Primoz Pristovsek; Mateja Mancek-Keber; Roman Jerala
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120.

Authors:  Adi Moseri; Subramanyam Tantry; Yael Sagi; Boris Arshava; Fred Naider; Jacob Anglister
Journal:  Virology       Date:  2010-03-26       Impact factor: 3.616

Review 3.  Protein engineering strategies for the development of viral vaccines and immunotherapeutics.

Authors:  Jayne F Koellhoffer; Chelsea D Higgins; Jonathan R Lai
Journal:  FEBS Lett       Date:  2013-10-21       Impact factor: 4.124

4.  Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein.

Authors:  Jayne F Koellhoffer; Gang Chen; Rohini G Sandesara; Shridhar Bale; Erica Ollmann Saphire; Kartik Chandran; Sachdev S Sidhu; Jonathan R Lai
Journal:  Chembiochem       Date:  2012-10-30       Impact factor: 3.164

Review 5.  Max Bergmann lecture protein epitope mimetics in the age of structural vaccinology.

Authors:  John A Robinson
Journal:  J Pept Sci       Date:  2013-01-24       Impact factor: 1.905

Review 6.  Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory.

Authors:  Marc H V Van Regenmortel
Journal:  Int J Mol Sci       Date:  2016-09-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.